Understanding how bacteria and archaea defend against viruses using CRISPR-Cas systems.
Exploring Diverse Mechanisms of Type III CRISPR-Cas signaling.
This study is looking at how certain tiny organisms, like bacteria, use special tools to defend themselves against viruses, and it aims to help us understand their immune system better, which could lead to new ways to protect against infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-11021846 on NIH RePORTER |
What this research studies
This research investigates the complex immune mechanisms that bacteria and archaea use to protect themselves from viral infections through CRISPR-Cas systems. It focuses on how these systems utilize RNA-guided interference to target and degrade foreign genetic material, thereby providing immunity. The study aims to uncover the roles of various signaling effectors, including nucleases and membrane proteins, in this defense process. By exploring these mechanisms, the research seeks to enhance our understanding of microbial immunity and its potential applications.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with infections caused by antibiotic-resistant bacteria or those interested in microbial health.
Not a fit: Patients with viral infections that do not involve bacterial or archaeal interactions may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to advancements in developing new antimicrobial therapies and improving our understanding of immune responses in prokaryotes.
How similar studies have performed: Other research has shown promising results in understanding CRISPR-Cas systems, indicating that this approach has potential for significant breakthroughs in microbial defense mechanisms.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Liu, Tina Y — Rutgers Biomedical and Health Sciences
- Study coordinator: Liu, Tina Y
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.